Three filings landed on BSE on Friday, August 7. By Monday morning my Bench had flagged them, and it hadn't flagged them alone. The pattern it built pulled in four SAST disclosures from April — filings I had never looked at — and matched them to the August open offer as a single acquisition sequence. Two offshore funds had quietly bought 13% of this company in April. In August they turned up as named allottees in the deal.

Reading the filings, tracing the people, connecting the sequence. This is what my Special Situations Bench does daily, for every listed small-cap (Request access at situations.humdingerhq.ai). What it is and how it works: The Special Situations Bench, a working desk, not a tip sheet

The stock closed at ₹27.10 that Monday. It has printed an upper circuit every session since and it's ₹48.58 today. I have not been able to buy a share.

What the board approved

Three filings landed on BSE on Friday, August 7. Read together they describe one transaction.

Kuber Udyog acquires 100% of Golden Ikon Fleet Management Private Limited through a share swap — issuing 7,62,85,000 new shares at ₹23.10 to Golden Ikon’s three owners, for consideration of ₹176.22 crore. No cash leaves the listed company for the purchase.

Alongside it, a cash preferential allotment: 3,95,50,000 shares plus 37,00,000 convertible warrants, also at ₹23.10. Roughly ₹91 crore of fresh money into the entity.

The existing objects get deleted and fleet management and vehicle rental objects go in. The company gets a new name, which the filing does not disclose. Authorised capital goes from ₹5 crore to ₹125 crore.

Then the arithmetic that matters. Pre-issue share capital is 34,33,000 shares. Post everything, it’s about 12,29,68,000. That’s 35.8x.

The Share Sale and Subscription Agreement triggered a mandatory open offer. Manav Bahri, Dinesh Popli and Ajay Dutta, with Trimudra Trade & Holdings as person acting in concert, must offer ₹23.35 per share for 26% of the expanded capital — 3,19,71,680 shares, ₹74.65 crore.

The business being bought

Golden Ikon did ₹182.50 crore in FY2024, ₹238.80 crore in FY2025 and ₹307.92 crore in FY2026 — around 30% a year, two years running. The filing sources these to Golden Ikon’s audited accounts.

It is not a startup. Established 2002, incorporated 2010, headquartered in Delhi. The filing describes a full-service fleet operator with 23 years in the business and offices nationwide, serving multinationals, luxury hotels, tour operators and events.

What the filing does not give is a single line below revenue. No PAT, no net worth, no asset base. Those numbers do exist — Golden Ikon is a private limited company, so its audited financials are sitting on the MCA portal for anyone willing to pay the download fee. I haven’t pulled them yet. Anyone sizing a position properly should, because ₹176.22 crore against ₹308 crore of revenue tells you nothing about whether you’re buying an owned fleet or a lease book.

Manav Bahri is the operator worth knowing. He’s a promoter and the Whole Time Director and CEO of Positron Energy Limited, which is listed. So he has a public-market record that exists independently of this deal and independently of Golden Ikon. Popli and Dutta are the other two Golden Ikon promoters.

The April trail

This is the part I would have missed reading the August filings cold, and it’s the part the Bench stitched together on its own.

Between April 13 and April 28, two Mauritius-domiciled protected cell companies built positions in what was then a ₹11 crore float:

Green Horizon Fund PCC – Cell 1 took 5.64%, essentially all of it in a single transaction on April 28. Altitude Investment Fund PCC – Cell 1 took 7.61%, with 63% of that concentrated on the same day.

Both funds are named cash allottees in the August 7 preferential issue. Green Horizon for 74,02,620 shares. Altitude for 73,59,300 shares plus 10,00,000 warrants. At ₹23.10.

In the same April window, the incumbent non-promoter block-holder — Hiten Nemchand Shah and his HUF — sold 4.39% of the company, with 3.64% liquidated on April 28. The HUF exited completely that day. The exchange filed a price-movement query on April 29.

So: an incumbent block clears out, two offshore funds pick up 13% between them, and four months later those same two funds are named in a board-sanctioned preferential entry at a fixed price. No PAC disclosure was filed by the funds in April, and none was required at those individual levels.

Both funds have form here. Altitude holds 14.21% of Axentra Corp, plus positions in SpiceJet and Nitco. Green Horizon holds 12.69% of Axentra and a stake in Dugar Housing. They co-invest.

The rest of the cash round is a similar cohort — Minerva Ventures Fund (roughly ₹750 crore of Indian equity, nine SME IPO anchor participations), Al Maha Investment Fund PCC, Norocos Opportunities Fund PCC, Tradewin Global Fund PCC, and Prudent Equity ACE Fund.

What the price did

₹12.82 on April 20, then sixteen straight upper circuits into mid-May as the offshore funds were buying. The exchange filed a price-movement query on April 29. Then a 49% unwind to ₹16.06 by July 7.

Since August 5 — two sessions before the filings — it has closed at an upper circuit every single day. Sixteen sessions, ₹23.42 to ₹48.58. No offer side for three weeks.

From the Bench flag on August 10, that’s +79% in twelve sessions, none of them tradeable.

The bull case

A funded pivot, not an announced one. This is the distinction I care about most. Plenty of micro-caps announce object changes into a hot sector and never fund them. Here the object change arrives with ₹176 crore of swap consideration and ₹91 crore of cash simultaneously, all earmarked to the fleet business specifically rather than general corporate purposes.

The incoming capital dwarfs the shell. ₹267 crore of combined consideration against a pre-deal market cap of ₹11 crore. Roughly 24x. Transactions at that ratio are not incremental.

There’s a real operating business with a real growth rate. ₹182 crore to ₹239 crore to ₹308 crore across FY24–FY26, on a 23-year-old operating history. Whatever else is uncertain, Golden Ikon is not a shell being swapped for a shell.

The operator has a listed-company record. Bahri runs Positron Energy as CEO and Whole Time Director. That’s checkable, and it’s separate from this transaction. In this class of deal, an identifiable operator with existing public-market accountability is the single most useful thing you can find.

The structure preserves the balance sheet. The acquisition is non-cash. The listed entity gets the operating business without spending its own money, and the cash leg adds capital on top.

The bear case

The Detailed Public Statement is late. The company’s own announcement promised it “on or before August 13.” Nothing has been filed since August 7. It’s the document that carries the post-transaction shareholding, and it’s thirteen days overdue in the middle of a circuit run.

Beneficial ownership is opaque. Five cash allottees are Mauritius protected cell companies with no ultimate beneficial owner disclosed, taking roughly 2.57 crore shares between them.

No margins on either side. Golden Ikon’s profitability is undisclosed. Kuber Udyog’s own Q1 revenue was ₹12 lakh, mostly fair-value gains rather than operations.

Authorised capital has 25x of headroom — ₹5 crore to ₹125 crore covers this deal and a great deal more issuance after it.

Where I land

I want in. I can’t get in — twelve consecutive circuits since the flag means there is nothing to buy.

The pattern is the one I look for: an object change funded at announcement rather than promised, an operator who already runs a listed company, and offshore money that pre-positioned in April and reappeared on the allottee list in August at a fixed price.

At ₹48.58 the stock is 108% above the open offer. I’ll take a starter position on the first genuinely two-sided session, and size it against the milestones below rather than against the chart.

What I’m watching

The overdue DPS. Promised on or before August 13, still not filed. It carries the post-transaction shareholding and the allottee detail. Its absence is currently the loudest thing about this deal.

Golden Ikon’s MCA financials. PAT, net worth, asset base, owned versus leased fleet. Available to anyone for a download fee. Highest-value hour of work on this name, and I need to do it.

The EGM notice — valuer’s name and the floor-price derivation behind ₹23.10.

Draft Letter of Offer and SEBI comments. Any observation on the offer price or the PAC disclosure would be material.

RBI on the NBFC licence surrender, filed July 24 and still pending as of the Public Announcement.

Q2 FY27 results, late October. First quarter that could show anything operational.

Friday’s filings were flagged by Monday morning, with April’s SAST disclosures pulled in alongside them, on a company nobody was watching. The Bench does that daily, for whatever files next. Request access at situations.humdingerhq.ai.

Sources. Kuber Udyog Ltd exchange filings on BSE between April 29 and August 7, 2026 — seventeen filings in the reviewed window, including the SAST disclosures of April 13–28, the FY2026 results of May 30, the NBFC licence surrender intimation of July 24, and the three concurrent filings of August 7, 2026 covering the acquisition board outcome, the open offer public announcement, and the preferential allotment. Manav Bahri’s Positron Energy role per public director records. Fund holding patterns for Altitude Investment Fund PCC and Green Horizon Fund PCC per Trendlyne and public FPI shareholding data. Golden Ikon’s three-year revenue series and business description are per the August 7 board-outcome filing, sourced there to Golden Ikon’s audited financials; its full accounts are available on the MCA portal and I have not yet pulled them. Price series and market data via BSE. Financial ratios via Screener.in.

Disclosure. I do not hold a position in Kuber Udyog Ltd (BSE: 539408). I have been trying to establish one and have been unable to, because the stock has been locked in upper circuit. I intend to buy on a tradeable print, which means my incentives are not neutral — read accordingly. I am not a SEBI-registered research analyst. This post is not investment advice or a recommendation. It is personal research shared for discussion, and the transaction carries the valuation-disclosure and beneficial-ownership gaps documented above. Please do your own work.

Keto Motors showed up on my own Bench two weeks ago, the morning after its August 2 filing on the first mobility-operator MoUs. Priority review, ownership-concentration flag, and a pattern I hadn’t seen before on a company I’d never heard of: a ₹1,447 crore electric-bus manufacturer that, on paper, didn’t exist a year ago.

It didn’t. Keto Motors Private Limited merged into a dormant listed shell called Taaza International through a court-approved scheme dated June 12, 2025. The name change took effect March 7, 2026. The company listed on the BSE two months after that. What’s trading today as “Keto Motors Limited” has been a listed company for about five months.

The Bench had already done the part I used to do by hand: pulled every filing since the scheme order, flagged the control change, and built out who the new owners actually are. I spent my week reading what it had already connected and checking it against the source filings myself.

What actually happened

The scheme did two things in one move. It merged an operating EV business into the shell, and it handed control to a new group.

Trinity Infraventures Limited, a Delhi-incorporated entity, went from 28.50% to 67.08% in a single allotment on March 31, 2026, through 4.31 crore new shares issued as part of the scheme. Because the control change rode inside a court-approved restructuring, it qualified for an exemption from the usual open offer requirement. Trinity’s stake more than doubled and nobody else got a chance to sell out at a fixed price.

Trinity didn’t do this alone. Count it together with 40 other parties acting in concert, two companies, a family trust whose ultimate owner isn’t disclosed, and 37 individuals, and the group now holds roughly 92.5% of the company. That leaves about 7.5% floating around in public hands, against a market cap of ₹1,447 crore. Almost all of that valuation is being set by a very small amount of tradeable stock.

One filing detail the Bench flagged directly. The original disclosure calculating the group’s post-scheme stake used the wrong denominator. It reported the number against total paid-up capital instead of the acquirer-plus-concert-party total. It took three and a half months for a corrected filing to show up, and the Bench had the correction lined up next to the original the day it landed.

Who’s actually behind it

This is where the Bench earns its keep. Forty-one names show up across these filings as promoter or concert party, and on their own, most of them tell you nothing. Click through the ones the Bench flags as connected and a different picture forms.

The name worth knowing is Lam Paul Sashikumar, a director of Trinity Infraventures with a documented history at Goldstone Technologies, the entity that came before Olectra Greentech, India’s largest listed electric-bus maker. Another concert party in this deal, Goldstone Power Private Limited, carries the same lineage. The Bench had both of them tagged the same way the moment their names appeared in a filing, without me having to already know who Goldstone Technologies was.

That’s not a small detail. The people assembling control here have already built and run an electric-bus company at scale. This isn’t a random holding company parking itself in a listed shell. It’s an EV operating group taking a shell public the fast way.

The rest of the ownership structure adds more texture than comfort. One concert party is a whole-time director at a subsidiary that’s described as Keto’s own fleet-technology partner, so the same people sit on both sides of what should be an arm’s-length commercial relationship. Another concert party runs the company supplying the bus’s digital fleet-management platform. A Taiwanese battery and powertrain firm is reported to hold around a 10% stake, though the terms of that arrangement aren’t in any public filing.

The product is real, even if it’s young

This isn’t a paper shell. Keto’s one product, the Urbanova KE9, a 9-metre electric bus, got its statutory type-approval certification from the government testing agency in early August. That’s a genuine, non-discretionary requirement before anyone can sell buses commercially in India. The company also announced non-binding interest from three fleet operators for 150 to 250 buses, plus a ₹300 crore manufacturing commitment tied to a Telangana state agreement, aiming for a facility that would eventually employ over 2,000 people.

None of the commercial side is under contract yet. The fleet-operator interest is explicitly non-binding. The ₹300 crore facility has no disclosed funding source or construction timeline attached to it.

What the numbers actually show

The first full-year results under the new structure came in weak, which is roughly what you’d expect from a pre-revenue industrial pivot: revenue of ₹2.1 crore against a net loss of ₹17.6 crore. Total assets nearly tripled year over year to ₹107 crore, but that’s mostly the scheme itself, not organic growth. Close to half of that asset base is goodwill and other intangibles from the merger accounting, not plant or inventory.

Borrowings jumped roughly sixteen-fold. There’s also a ₹38 crore receivable on loans the company has given out, with no disclosure of who’s on the other end.

The CFO resigned three days before the board approved these very results, the first financial statements under the new ownership, and no successor has been named since.

Where this sits

This is a real operating pivot, run by people who’ve done it before in the same sector, wrapped around one of the more aggressive ownership-concentration structures I’ve come across this year. A 92.5% combined stake with no open-offer exit for anyone else isn’t a footnote here. It’s the central fact of the whole setup. Whoever holds the remaining 7.5% is along for whatever Trinity’s group decides to do next, with almost no ability to influence it and almost no stock available if they want out.

The EV bus opportunity in India is real and the operating pedigree behind this deal is genuine too. Whether that ever translates into value for the shareholders who don’t control the company is a separate question from whether the business itself works.

A filing like the March 31 one lands on the Bench the same morning it’s made, for whatever company files next. Request access at situations.humdingerhq.ai.

What I’m watching

First firm order. The gap between a non-binding MoU and an actual purchase order is the whole commercial story here.

CFO appointment. The seat has been empty since before the first post-merger results were even approved.

Funding disclosure on the ₹300 crore facility commitment. A capex number with no financing plan attached is a promise, not a project.

Any further correction to the ownership disclosures, given the calculation error already found once.

Related-party detail on the undisclosed loan receivable and the fleet-technology and battery-supply arrangements, given how many of the same people sit on both sides of Keto’s commercial relationships.

Sources. Keto Motors Limited (formerly Taaza International Limited, BSE: 537392) exchange filings, including the NCLT-approved scheme of arrangement, the shareholding disclosures documenting Trinity Infraventures’ stake increase and the wider concert-party group’s holdings, the corrected shareholding disclosure filed in July, the CMVR type-approval certification filing, the product-launch and mobility-operator MoU announcements, the Telangana manufacturing MoU, and FY2026 audited financial results. Company background and promoter-group EV-sector history from public filings and press coverage. Financial and price data from BSE and Screener.in.

Disclosure. I don’t hold a position in Keto Motors Ltd. I’m not a SEBI-registered research analyst. This post isn’t investment advice or a recommendation, it’s personal research shared for discussion. The ownership-concentration and disclosure-quality concerns above are real things to weigh if you’re looking at this stock. Do your own work.

The problem it solves

Every multibagger backstory I’ve ever written follows the same arc: the company disclosed everything, publicly, months before the market noticed. A new owner took control. A serious investor quietly built a position across eight small disclosures. A boring company changed what it’s allowed to do, raised money, and renamed itself. All of it sat in exchange filings that almost nobody reads - because there are hundreds of them a day, written in language designed to be skimmed past.

The Bench scans them all daily — and reads the ones that matter in full when you ask. Not to give you a buy list - to give you a desk: the same raw material a full-time special-situations analyst works with, already sorted, connected, and traceable back to the source documents.

How you actually work it

Here’s the loop, the way I use it myself.

Start anywhere something catches your eye. Three entry points:

• Actionables — companies where the filed events already match one of fourteen documented situation shapes (a reverse merger, an accumulation campaign, a turnaround acquisition, a capex build-out…). Each card tells you which shape fired, how completely the filings document it (●●● Complete / ●●○ Partial / ●○○ Thin), and gives you a written analysis of what the record shows. This is the “most developed” queue — but it’s the end of the pipeline, not the whole product.

• Patterns — simpler, earlier signals: a capital infusion happened, an accumulation is underway, a transformation is starting. These are event clusters the desk spotted before anyone has done deep work on them. Each card shows the date of the filing that triggered it. This is where the undiscovered stuff lives — a pattern card is an invitation to investigate, not a conclusion.

• The filings themselves — every disclosure the desk scanned, scored for attention (how big, how unusual, who’s involved), searchable by company. Sometimes one strange filing is the whole thesis.

Then put the desk to work. This is the core action, and where the AI earns its keep. When something looks interesting, you ask the Bench to analyse it: it reads every one of that company’s filings in your chosen window in full — not headlines, the actual documents — researches the people and entities behind each event, and writes you an investment view: what happened, in what sequence, who drove it, how completely the record documents the situation, and whether the filed facts currently lean for or against minority shareholders. That’s the work that would have cost you an afternoon of PDF-reading and Googling names, done while you get coffee. And if the story looks like it started earlier, you widen the window — a year, two years, three — and the desk rebuilds the picture from the longer record. That’s how the slow stories surface: the stake built across thirty months of small disclosures, the pledge released filing by filing. Reading everything already on the Bench is free; credits are spent only when you ask for fresh analysis like this.

Then pull the thread on the people. Now the human part starts. Every acquirer, investor, and director in the written analysis is a live link into the Bench’s entity graph. Click a name and you get their documented track record: which other listed companies they’ve appeared in, what happened there, who they show up alongside. When someone crosses 5% in a forgotten micro-cap, the first question is always “who is this person?” - the Bench usually already knows, and one situation quietly becomes a map of three.

Then decide for yourself. The Bench never tells you what a stock is worth or what to do. Every label on it describes documentation, not destiny: whether the filed record of a situation is complete or thin, whether the documented facts currently lean for or against minority shareholders (dilution and pledging on one side; fresh locked-in capital and released pledges on the other). A fully documented setup can still fail. A thin one can still work. The desk’s job is to make sure you’re forming your view from the complete record — the judgment stays yours.

What a session looks like in practice

Take a real one — the story behind my most-read post. A capital-infusion pattern fires on Lokesh Machines, a Hyderabad machine-tools maker most screens ignore. The subscriber to the raise is something called “Zandra Herbs & Plantations LLP” — a name that means nothing to anyone. So you ask the Bench to analyse the filings relevant to the pattern (which you can see on the Bench itself). A few minutes later you’re reading a written view of the situation: the sequence of events dated and ordered, the people behind each one researched, the record graded for how completely it’s documented and for what it currently means for minority shareholders. And in that analysis, the anonymous LLP has become people: the entity research traces it to Sharvil and Pankaj Patel — the promoters of Zydus Lifesciences. Two pharma billionaires quietly entering a ₹500-crore machine-tools company through an Ahmedabad LLP. That’s worth more history, so you widen the window — and the desk finds the promoters themselves converting warrants and putting in their own money a year earlier, then the family adding five members to the promoter group. Twenty minutes, and you’re holding what took me a full evening of PDF-reading when I wrote that post by hand: a documented, dated, researched sequence of who did what. Whether it’s investable is your call — but you’re asking that question months before it’s a story anyone writes.

Who it’s for

People who already like doing the work — reading, connecting, forming a view — and are limited by the impossible surface area of small-cap disclosures, not by lack of judgment. If you want someone to tell you what to buy, this will frustrate you; it refuses to, on purpose.

It’s in invite-only beta. Request access at situations.humdingerhq.ai — approved invites arrive by email (check Promotions/Spam if nothing shows up within a day).

I hold a small position in Lokesh Machines. Nothing here is investment advice or a recommendation to buy, sell or hold any security. situations.humdingerhq.ai is not a SEBI-registered research analyst or investment adviser.

Between February and August this year, it went through one of the most complete control transitions I’ve seen in the Indian small-cap space. In three clean phases. In public view the entire time.

Phase 1 — New money, new purpose (February–March)

At a shareholder meeting on February 19, shareholders approved a five-resolution bundle: new Articles, higher authorised capital, a change in the company’s stated objects, a preferential allotment of 12.07 lakh shares, and 19.9 lakh convertible warrants — all passing with 99.99% of votes.

On March 20, the board allotted all of it, at ₹115 per share, to nine allottees — none of whom held a single prior share. On a fully diluted basis, nine strangers acquired 67.87% of the company from zero. Among them: Sreeram Reddy Vanga, founder of Kofluence and OpenPlay, explicitly designated for reclassification as promoter — and a Nikhil Kamath-linked entity as co-investor.

These disclosures were public on February 20 and March 20. The Bench flagged the pattern — fresh capital, first-time significant holders, objects change — the same mornings. This is what that looks like →

Phase 2 — The mandatory exit door (March–April)

Vanga’s promoter designation triggered a mandatory open offer: up to 7.11 lakh shares (26.13% of emerging voting capital) at the same ₹115, opened March 25, closed April 10. An unconditional cash offer — the formal, regulator-supervised moment where existing shareholders get told, in writing, that control has changed hands.

Phase 3 — The old company stops existing (May–August)

Then the sweep: board reconstitution, management replacement, the CFO resigning with a letter that explicitly cited “recent changes in control of the Company” as the reason. And finally the rename — Photon Capital Advisors became Inference Platforms Limited, with a stated pivot from NBFC-adjacent capital advisory to AI infrastructure.

A forgotten listed shell, rebuilt end to end in about 120 days: new owners, new board, new management, new name, new business.

Here’s my problem with this post

You’re reading it in August. Phase 1 was disclosed in February.

Every deep-dive I’ve published here — NINtec’s AI pivot, the AMPL Capital control filing — has the same flaw: it’s the story after the fact. The disclosures were public weeks or months before I connected them into a narrative. In special situations, that gap is everything. The story is worthless to you if the setup already played out.

A newsletter can’t close that gap. So I built something that does.

The Special Situations Bench

For the past months I’ve been building the tool I wanted as an investor: special-situations intelligence over the disclosures of every BSE-listed company, every day — mid, small and micro-caps included.

• It reads the daily disclosure flow and detects documented situation shapes — control transitions like Photon’s, quiet accumulation by investors with real track records, funded capacity expansions, marquee order momentum, promoter deleveraging — fourteen shapes, each defined by what filings actually document, never by opinion.

• It maintains an entity graph — past 85,000 people and companies and growing daily — so when a name appears in a filing, you see where that name has appeared before, what they’ve built, what they’ve backed.

• And it’s a working desk, not a feed: point it at any listed company and it assembles the documented picture — who is involved, how significant, how well-corroborated — so you build your own view of the situation as it unfolds.

Photon’s three phases above? Each one surfaced on the Bench the morning it was disclosed, connected to the phases before it.

Access

The Bench is in invite-only beta. If you want in: situations.humdingerhq.ai → Request access. I’m admitting a small beta cohort from this list first. Approved invites arrive by email — check Promotions/Spam folder if you don't see it within a day.

The posts here will keep coming — the deep-dives aren’t going anywhere. But now, when a story ends with “the filings were public all along,” you’ll have the thing that was watching them on day zero.

The developments in this story surfaced as public disclosures between February 20 and August 8, 2026. Bench users saw them connected the same mornings. situations.humdingerhq.ai

Disclosure: I hold no position in Photon Capital Advisors / Inference Platforms Limited . I am not a SEBI-registered research analyst. Nothing here is investment advice or a recommendation to buy, sell, or hold any security — this is a descriptive account of publicly disclosed corporate events.

Sources: BSE corporate disclosures by Photon Capital Advisors Ltd (February 10 – August 8, 2026): EGM notice and voting results, preferential allotment and warrant issuance intimations, open offer documents, board and management change intimations, and the name-change certification.

Pankaj Polymers came up on my screener last Sunday. I hadn’t heard of it. A ₹44 crore polymer micro-cap in Secunderabad, trading around ₹80.

What made me look twice was the July 24 board outcome. In one meeting, this company approved a preferential issue, changed its name to Rupia Tech/Fin/Fintech Limited, ripped out its object clause and swapped polymers for fintech, moved its registered office from Telangana to Delhi, and swapped its statutory auditor. Five things. One sitting. Shareholder vote on August 22.

I read the last six months of filings backwards to figure out how it got here.

What actually happened

Between January and June, ownership changed hands completely.

A Share Purchase Agreement dated January 14, 2026 committed the Goel-family promoter group to sell 58.15% of the company (32,23,627 shares) to four incoming acquirers: Vikas Garg, Rahul Nagar, Sandeep Jain, Himanshu Arora. A mandatory open offer was triggered under the SEBI Takeover Code at ₹40 per share. The stock was already trading well above ₹40, so almost nobody tendered. That’s normal in this class of deal.

The SPA then executed in five tranches. First 11.86% from Pankaj Capfin (end of March). Then 18.86% on May 12 from four Goel entities. Then 18.14% on May 14–15 from Pankaj Strips. Then 8.38% on May 18 from Kanchan and Nita Goel. And a small residual lot on May 25 to close it out.

By late May, the acquirer group held: Rahul Nagar 20.29%, Vikas Garg 20.29%, Sandeep Jain 13.05%, Himanshu Arora 4.51%.

The board changed in two moves. On June 9, five new directors came in, including Mayank Chawla as CEO/Whole-time Director on a five-year term. On June 19, the entire incumbent Goel leadership resigned in a single day, all citing “change in management.” Aman Goel resigned ten days later. By end of June, the Goel family was fully out of the boardroom.

Then July 24 happened. The board approved a ₹24.9 crore preferential issue (8.55 lakh equity shares at ₹81, plus 22.20 lakh warrants at ₹81), the name change, the MOA rewrite, the office move, and a new auditor. All conditional on shareholder ratification at the EGM on August 22.

Who the buyers are

Three of the four acquirers share the same kredmint.com email domain in the SEBI filings. That’s a small detail buried in the disclosures but it’s the whole story.

Kredmint Technologies Private Limited is a Noida-based embedded-finance startup they co-founded in June 2022. It provides working-capital financing to MSMEs, specifically around supply-chain visibility and control. It raised $2 million in its first funding round in December 2022.

The one you want to know about is Vikas Garg. Chartered Accountant. Twenty-plus years in finance — ICICI Bank, then goibibo, then Paytm, where he spent over a decade and rose to become the group CFO. He left Paytm in 2022 to co-found Kredmint. His LinkedIn is public and the transition is documented across YourStory, Exchange4media, BW Disrupt.

Mayank Chawla, the incoming CEO, also comes from a Paytm/fintech background.

Which is the point. This is not a shell taken over by phantoms. It’s a shell being taken over by a group of people who’ve built and scaled fintech before.

The bull case

Four things stack the same direction.

The pattern shape is accumulation-then-deployment. Twelve successive SAST filings over five months, a concentrated four-member group, structured transfer followed by capital deployment and business pivot. Accumulate, then transform. That sequence keeps showing up in Indian smart-money situations.

It’s a Paytm-mafia cluster. Vikas Garg was Paytm’s CFO. Rahul Nagar was a VP of Business at Paytm. Himanshu Arora was Principal Product Manager at Gaana. Mayank Chawla is fintech/Paytm background. Kredmint isn’t a phantom; it’s a two-year-old embedded-finance startup seeded by exactly the sort of people who tend to know if an early-stage fintech is going to work.

Kredmint’s private captable is stacked. The $2M seed round was backed by Kunal Shah (CRED), Ashneer Grover (BharatPe), Shankar Nath and Amit Sinha (both ex-Paytm), Amit Lakhotia (Park+), Manish Amin (Yatra), plus two Indian VCs and one Singapore-based VC. That’s not a captable strangers put together. And notably, at least one of those angels — Shankar Nath — is now also a warrant allottee in the Pankaj Polymers preferential. Kredmint’s private angel base is being extended into the listed vehicle.

The listed vehicle is the point. For a two-year-old private fintech, going public via a shell conversion is faster and cheaper than filing a DRHP. That doesn’t make it wrong. It makes it opportunistic.

What I keep coming back to on the bear side

Five deal-specific concerns. Not features of the transaction class, actual issues in this particular deal.

The first one is the cleanest. Mayank Chawla, appointed CEO on June 9, is the single largest equity allottee in the preferential issue his board approved on July 24. ₹1.01 crore of the ₹6.93 crore equity portion. A competent independent board should have handled the mechanics differently. Same person approves the issue and gets the biggest slice? That’s a governance data point regardless of what you think of the deal.

The pricing basis for the preferential is also opaque. There’s no ICDR floor-price computation in the filing, no registered valuer details, no justification for why the price is ₹81 versus something else. UBOs are undisclosed across all 36 allottees. Multiple allottees share surnames (Jain family cluster, Goyal HUFs, Sansi family), which could be related-party structuring or could just be coincidence. Some allottees are clearly Kredmint angels. Others don’t identify at all in any public source I could find.

Then there’s warrant overhang. 22.20 lakh warrants at ₹81 is a material future dilution — roughly 40% of the post-equity-issue paid-up capital if they all convert over the eighteen-month window. Whether the warrant-holders actually put up the balance and convert, or let them lapse, is going to tell you a lot about whether this is genuine capital or just optionality being handed around.

Execution risk on the pivot is real too. Kredmint is two years old and raised $2 million. That’s a foothold, not a franchise. The bull case underwrites the listed vehicle becoming a fintech, not one that already works at scale.

And the micro-cap liquidity problem. Free float is around ₹18.6 crore. A big slice of the equity is locked in acquirer hands, another slice is preferential and warrant. On-market liquidity for anyone who wants to sell is thin. That doesn’t kill the setup but it does mean you have to size for the exit door, not just the entry.

Where I land

Small position - starter. Planning to add on execution proof.

The setup is asymmetric. If the Kredmint operators execute the pivot, the re-rating from a ₹44 crore polymer-shell mcap to something that reflects a listed fintech book is very large. If they don’t, the downside is bounded by where the polymer shell trades today. The disclosure gaps in the July 24 filing mean the “if they don’t” scenario is genuinely possible, not theoretical. Which is why I entered small.

The August 22 EGM is the first checkpoint. It is not the exit. Each subsequent milestone that lands cleanly - warrant subscription discipline, KMP appointments, first integrated financials, any SEBI query cleared without drama - is a reason to add.

What I’m watching

• August 22 EGM outcome. Does the ordinary shareholder base ratify all five agenda items? Any dissent noted in the voting result?

• CFO appointment. The role has been vacant since the June 19 mass resignation.

• SEBI or BSE query on the preferential issue — pricing basis, allottee disclosures, or the statutory-auditor exit. Any query is a material signal.

• Warrant subscription discipline. 25% upfront payment on the warrant portion is due within 15 days of EGM approval. Any slippage is a very loud signal.

• FY26 annual report (due by September 30) — first full financial disclosure under the new board. Cash reconciliation, related-party transactions, and management-discussion narrative are the sections that will actually matter.

• First Kredmint-integrated operational disclosure — if the fintech business gets migrated into the listed vehicle (rather than sitting alongside it), the mechanics of that integration will be the real tell.

Sources. Pankaj Polymers Ltd exchange filings on BSE from January 14 to July 24, 2026, including the SPA intimation, Letter of Offer under SEBI SAST Regulations, twelve tranche-completion disclosures, board reconstitution filings (June 9 and 19, 2026), and the July 24, 2026 board outcome covering the preferential issue, MOA substitution, name change, office shift, and auditor replacement. Vikas Garg / Kredmint / Paytm background per LinkedIn and startup press (BW Disrupt, YourStory, Exchange4media). Kredmint $2M seed round investor roster per Entrackr, Indian Startup News, and Startup Story Media. Financial and price data via BSE and Screener.in.

Disclosure. I hold a small position in Pankaj Polymers Ltd (BSE: 531280). I am not a SEBI-registered research analyst. This post is not investment advice or a recommendation — it is personal research shared for discussion. Please do your own work.

I hadn’t paid attention to it in years. It emerged from insolvency in December 2022 under an NCLT-approved resolution plan. In my head it was still a wreck. So I opened the last six months of filings expecting more of the same.

That’s not what the filings show.

What the filings actually show

February 12, 2026 — the rights issue. Board approves a 1:5-ish rights issue at ₹64 per share, aggregating up to ~₹93 Cr. The mechanic is unusual. The promoter — Pristine Infraways Logistics Private Limited — waives its entire entitlement. It doesn’t subscribe and doesn’t renounce. The issue is offered exclusively to public shareholders.

The original proposed size was ₹110 Cr. After the promoter’s waiver, the final size is ₹93.03 Cr. The stock exchanges had raised queries on the Draft Letter of Offer before granting in-principle approval — the January 30 board meeting was rescheduled because of those queries. Whatever they asked, the answer was: promoter is out, only the public gets to subscribe.

March 12, 2026 — full allotment. 1,45,35,790 new shares issued. Paid-up share count rises from 6.52 crore to 7.98 crore — a 22.3% increase, entirely absorbed by the public float. Proceeds go to debt reduction.

May 29, 2026 — the numbers. Audited FY26 consolidated results confirm what the balance sheet has been trying to say. Revenue ₹385.7 Cr vs ₹221.8 Cr in FY25 — +73.9% YoY. EBITDA ₹78.3 Cr vs ₹21.5 Cr — +263.7% YoY. EBITDA margin from 9.7% to 20.3%. Consolidated debt-to-equity from 4.1x to 1.6x in a single year.

The same press release also confirms a ₹3,422 Cr overburden removal order from South Eastern Coalfields Limited (a Coal India subsidiary) for the Porda-Chimtopani Open Cast Project in Raigarh, Chhattisgarh. Eleven-year execution timeline. Roughly 8.9x FY26 revenue on the order book, from a single PSU counterparty.

June 30, 2026 — non-core asset sale. Sical disposes of a Madhavaram (Chennai) land parcel — 79,627 sq ft — to Roshan Foundations Limited for ₹18 Cr. Non-related party (linked to the Galada Group of Chennai via director network). Executed pursuant to the NCLT resolution plan. The asset contributed nil revenue in FY26.

The parent context

Sical’s promoter, Pristine Infraways Logistics, is part of the broader Pristine Group — a rail-focused multimodal logistics platform owned by Global Infrastructure Partners (GIP), the infrastructure fund BlackRock acquired for $12.5 billion in 2024.

On June 29, 2026, Pristine Logistics & Infraprojects Limited filed a confidential DRHP with SEBI, per BusinessToday and multiple market outlets. Reported target valuation is around ₹5,000 Cr with an issue size of roughly ₹1,200 Cr. That reframes the six months of Sical filings.

Balance-sheet cleanup, promoter stepping out of a dilutive event that mechanically raises public float toward the 25% minimum, disposal of non-core assets under the NCLT plan, a high-visibility PSU order win — these are not unrelated moves. They read like the listed subsidiary being tidied up before the parent group’s own listing.

I can’t prove intent. But the pattern is coherent.

What the price did

The filings signalled the turnaround before the market re-rated:

• Feb 9 — Pre-rights baseline: ₹91.90

• Feb 13 — Board approves rights issue: ₹94.35

• Feb 26 — Rights issue opens: ₹65.41 (ex-rights drop)

• Mar 10 — Rights closes: ₹65.25

• Apr 16 — Post-allotment: ₹65.84

• May 29 — ₹3,422 Cr SECL order press release: ₹65.58

• Jun 8 — Market catches on: ₹76.39

• Today (Jul 15) — ~₹90

The ex-rights drop from ~₹94 to ~₹65 in February was mechanical dilution math. What matters is the trough. The stock sat flat at ~₹65 for three full months after the rights issue closed — through the SECL order announcement itself, which the market appears to have shrugged off for a week. Then between Jun 8 and today, it’s moved +18% to ~₹90. From the Feb 26 floor, that’s +38%.

The filings had the information the market needed. It just took a while to price it in.

The bull case

Four things stack the same direction.

Operating numbers already tell the turnaround story. Revenue nearly doubled. EBITDA more than tripled. Margins expanded 1,060 basis points. This isn’t a hope-based turnaround.

The order book is transformational. A single ₹3,422 Cr order from a Coal India subsidiary is roughly 8.9x current revenue and gives an ~11-year runway. That’s the kind of contract that changes an equity story.

Balance sheet risk is materially lower. D/E from 4.1x to 1.6x is a genuine structural improvement. The rights issue proceeds went straight to debt reduction; the non-core asset sales continue that trajectory.

The parent is preparing its own listing. A GIP/BlackRock-backed platform doesn’t file a DRHP without cleaning up all its group entities. Whether Sical stays listed independently, gets merged, or gets a takeover offer, the pre-IPO tidying-up context is a tailwind.

The bear case

Three honest concerns - and honestly, none of them are structural indictments.

• FY26 margins are off a low base. EBITDA of ₹78.3 Cr is up 264% YoY — but off a FY25 base of ₹21.5 Cr. Q1 FY27 is the first quarter that tests whether the 20.3% margin holds on a normalised comparable. Until then, the extrapolation to a run-rate business is a bet, not a fact.

• The best re-rating leg has already run. From ₹65 in February to ~₹90 today is ~38% in five months. The market has already priced the SECL order, the debt reduction, and the FY26 numbers. Forward return depends on the next leg of execution — Q1 FY27 confirmation, SECL revenue booking, and RHP-triggered visibility on the parent. The margin of safety has narrowed.

• Disclosure quality tail. Same-day clarificatory filing correcting terms approved the previous day. Stock-exchange queries on the Draft Letter of Offer. A subsequent press release citing the wrong BSE scrip code. Compliance officer’s email domain is Pristine’s, not Sical’s. Individually minor, cumulatively a governance-integration flag worth sizing - but not a deal-breaker.

Where I land

Watching, not buying - yet.

The setup is genuinely attractive: a post-IBC turnaround with visible operating momentum, a transformational PSU order, a structurally lower balance sheet, and a GIP/BlackRock-owned parent heading to IPO. Any one of those is worth reading; four together is unusual.

What holds me back is that the biggest re-rating leg has already run — from ₹65 in late February to ~₹90 today. The market has priced the FY26 numbers, the SECL order, and the balance sheet cleanup. The forward return now depends on the next leg — Q1 FY27 confirmation, first SECL revenue booking, and the Pristine DRHP becoming public (that’s when the group’s own valuation gets marked). Any of those three, or a pullback that widens the entry margin, and this becomes actionable.

What I’m watching

• Q1 FY27 results — first test of whether FY26 EBITDA margins hold on a normalised base.

• The Pristine DRHP going public — reframes Sical’s position within the group. SEBI observations on the confidential DRHP are the next visible milestone.

• SECL order execution updates — first revenue booking from the ₹3,422 Cr contract in the FY27 quarters.

• Post-allotment shareholding pattern — confirms the promoter’s revised percentage and whether the 25% public float threshold is now met.

Sources. Sical Logistics exchange filings on BSE from January to June 2026: board meeting notice (January 30, 2026), rights issue board approval and clarificatory filing (February 12–14, 2026), Letter of Offer (February 16, 2026), rights issue closure and allotment intimations (March 10 and 12, 2026), FY26 press release (May 29, 2026), and non-core land sale intimation (June 30, 2026). Pristine Logistics & Infraprojects confidential DRHP filing per BusinessToday (June 29, 2026) and other market outlets; GIP/BlackRock ownership context per public reporting. Financial and price data via BSE and Screener.in.

Disclosure. I do not hold a position in Sical Logistics Ltd (BSE: 520086). I am tracking the situation closely. I am not a SEBI-registered research analyst. This post is not investment advice or a recommendation — it is personal research shared for discussion. Please do your own work.

I was going through last week’s QIP allotment filings when one line stopped me.

A single entity had just taken 34.38% of an ₹800 crore institutional placement in a mid-cap pharma company. QIPs are supposed to broaden institutional ownership. This one didn’t.

The company is Blue Jet Healthcare Ltd — specialty pharma, ₹11,540 Cr market cap, LTP ₹614. The allottee is Shamyak Investment Private Limited, a Mumbai-based NBFC.

The allotment filing lists three directors: Haresh Jayantilal Shah, Dipesh Lalitchandra Doshi, Vikas Harilal Mapara. No UBO disclosure. No mention of any established relationship to Blue Jet’s promoters.

So I pulled the corporate filings on the directors.

What the director filings show

Two of Shamyak’s three directors — Haresh Jayantilal Shah and Dipesh Lalitchandra Doshi — are designated partners in a Mumbai LLP called Sahaj Advisory Services LLP.

Their two co-partners in that LLP are Nemish Shantilal Shah (co-founder of ENAM) and Krutarth Nemish Shah (his son, a director of ENAM Holdings Pvt Ltd).

Family-office-scale partnerships don’t get formed casually. Shamyak’s ~₹7,900 Cr public equity book also reads like a Nemish Shah-flavour portfolio — big-cap quality names, held for decades. Blue Jet is now on that list.

The rest of the QIP allottee list

The second-largest block — 33.75% of the issue — went to seven ICICI Prudential Mutual Fund schemes: PHD Fund, Manufacturing Fund, MNC Fund, Quant Fund, Equity Savings Fund, Value Fund, Quality Fund.

Seven schemes. Five different mandate types — thematic, sector, quant, value, quality. Same placement, same day.

That’s not one PM’s bet. That’s the ICICI Pru investment platform saying yes to Blue Jet across five different frameworks.

Between Shamyak and ICICI Prudential, ~68% of the QIP is accounted for by two anchors. The remaining ~32% will show up in the Placement Document dated July 9, 2026.

Placement mechanics. Opened July 6. Closed July 9. Three days. 1,58,10,276 shares at ₹506 — raising ₹799.98 Cr. Fast placements mean the book was covered without trouble.

What the money is for

The board approved Phase 1 of a greenfield facility at Anakapalli, Andhra Pradesh — approved outlay ~₹1,000 Cr on July 31, 2025. Long-term site potential up to ₹2,300 Cr, but that’s conditional on further approvals; I’m counting only Phase 1 as firm.

₹1,000 Cr on an ₹11,540 Cr market cap. Not maintenance capex.

Bhoomi Pujan on February 28, 2026. Andhra IT minister Nara Lokesh attended — state cover for the site.

No filing formally earmarks the ₹800 Cr QIP against the ₹1,000 Cr Vizag capex. But the quantum and the timing are hard to miss.

What the setup looks like

Three independent signals, same direction:

• A vehicle directed by Nemish Shah’s LLP partners takes 34% of the placement.

• Seven schemes of one of India’s largest AMCs subscribe across five different mandates.

• The company simultaneously executes its largest-ever capacity commitment, with state-government cover.

Three streams. Same story. This is a bull case.

The one risk

Promoter Akshay Bansarilal Arora sold 6.19% in September 2025 via an on-exchange OFS. The sale was mandatory — the promoter group was above the regulatory 75% ceiling and had to come down. Post-sale, the group moved from 86.00% to 79.81%.

79.81% is still above 75%. The QIP dilutes the promoter percentage mechanically by enlarging the share base, but doesn’t transfer promoter shares to the public. More mandatory promoter selling is a live obligation.

Known, quantifiable, time-bounded — the kind of overhang that compresses entry prices, not raises them.

What I’m watching

• The recalculated post-QIP promoter percentage. If still comfortably above 75%, another OFS is coming.

• The Placement Document (July 9) — full allottee list for the ~32% tail.

• A use-of-proceeds statement — formal earmarking of ₹800 Cr against Vizag.

• Vizag construction milestones — clearances, physical progress. Commissioning likely 2027–2028.

• Q1 FY2027 results — first quarter with the enlarged share base.

Where I land

Holding. Accumulating.

When two of the three directors of a QIP’s largest single allottee are business partners with Nemish Shah in a family-office-scale LLP, and the same placement clears seven ICICI Prudential schemes across five different mandates, and the company is deploying its largest-ever capex under state-government cover — those three streams don’t line up by accident. That is the kind of alignment I look for.

The mandatory-selling overhang is a real drag on price for now. That’s the trade

Sources. Blue Jet Healthcare exchange filings on BSE from September 2025 to July 2026: Reg 30 intimation of promoter sale (September 12, 2025), SAST 29(2) disclosure (September 15, 2025), Notice and voting result of 57th AGM (September 2025), Vizag press release (February 28, 2026), Investment & Finance Committee QIP-opening intimation (July 6, 2026), and QIP allotment outcome intimation (July 9, 2026). Sahaj Advisory Services LLP designated partner listing per ZaubaCorp (LLPIN AAA-0768). Nemish Shah / ENAM Holdings background per ENAM Holdings management page and FLAME University governing-body listing. Shamyak Investment portfolio data via Trendlyne (Q2 2026 disclosed holdings).

Disclosure. I hold a position in Blue Jet Healthcare Ltd. I am not a SEBI-registered research analyst. This post is not investment advice or a recommendation — it is personal research shared for discussion. Please do your own work.

AMPL Capital Limited (BSE: 539598) — until June 20 named Credent Global Finance — is a nano-cap NBFC. Market cap ₹233 Cr, LTP ₹38.39, ROE 28.8%, ROCE 25.3%, P/E 8.35x. A small but respectable lending business trading at a modest multiple.

In five weeks between late May and early July 2026, its entire ownership architecture was rewritten. A mandatory open offer for 26% of equity has been filed. Two large historic shareholders exited near-completely. A newly-incorporated LLP with ₹2 lakh paid-up capital emerged as the largest single buyer, poised to hold ~17% or potentially majority control. The company’s name changed halfway through the sequence.

The acquiring party is the promoter family of DP Abhushan Ltd — a listed Ratlam-based jewellery company with pre-independence origins. What follows reads less like a routine control transition and more like a well-choreographed control acquisition of a listed nano-cap NBFC.

The five-week sequence

• May 29–30 — Aditya Vikram Kanoria, MD-CFO of the then-Credent Global Finance, secures board approval to subscribe to 76 lakh convertible warrants at ₹30 each — aggregating ₹22.80 Cr, nearly doubling his stake from 13.14% to 22.69% on a fully diluted basis. He is deploying capital roughly equal to his entire disclosed listed portfolio.

• June 4 — DP Global Wealth Management LLP — a vehicle incorporated in Ratlam on November 4, 2025 with ₹2 lakh paid-up capital and Vikas and Santosh Kataria as partners — is first disclosed as holding 2.03%.

• June 12 — The Kataria LLP crosses 3.22% (7.33 lakh additional shares). The first Chheda-family selling begins around the same time.

• June 19–25 — The Kataria LLP crosses 6.50% (20.19 lakh shares on June 23–24), then reaches 8.96% (15.09 lakh more on June 25). Concurrently, the Chheda group (Mohit, Dilip, Nayna, and Laxmi Trading & Investment) sells ~59 lakh shares, reducing their combined holding from ~9.95% to ~0.35%. Roughly 9.6% of equity changes hands in six trading days.

• June 20 — Certificate of Incorporation for the name change from Credent Global Finance to AMPL Capital Limited is issued by ROC Mumbai — falling exactly between the first Chheda exits and the largest Kataria accumulation tranches.

• June 29–30 — The Kataria LLP acquires 50.08 lakh shares in a single tranche, reaching 17.11%. Same two days, Minerva Ventures Fund (a Mauritius-based AIF) exits 32 lakh shares (5.21%).

• June 30 — Public announcement of a mandatory open offer at ₹30 per share for 26% of total equity, aggregating ₹47.94 Cr, with stated intent to acquire control. If fully subscribed, the Kataria group could hold ~51% of AMPL Capital.

In sequence — an LLP incorporated seven months earlier, a name change slotted precisely between exits and acquisitions, two large historic shareholders exiting exactly as the LLP accumulates — the pattern reads as one continuous, planned takeover.

What the bull case requires

Two high-conviction actors are deploying capital simultaneously at ₹30. Kanoria (MD-CFO, existing 13.14% promoter) via warrants (~90% of his disclosed listed portfolio, ₹22.80 Cr). The Kataria family (combined disclosed portfolio ~₹182 Cr, concentrated in DP Abhushan and AMPL) building a controlling stake via the LLP. Both increasing exposure at the same price with no exit signals. That kind of alignment on a nano-cap is unusual.

The fundamentals are independently strong. 28.8% ROE, 25.3% ROCE, 8.35x P/E — versus quality NBFC peers at 15-20x. Standard re-rating math alone implies meaningful upside, before any control-contest premium.

The offer floor sits below the re-rated market price. ₹30 is where all the accumulation happened, and where the stock traded through June 29. Once the announcement dropped, the market re-rated to ~₹38 — pricing a competing bid, a DP Abhushan integration, or a standalone NBFC re-rating. Public shareholders have limited incentive to tender at ₹30 — meaning the Kataria group likely ends up at less than the full 51% they’ve filed for, leaving a contested multi-promoter structure that could catalyse a bidding war, a negotiated minority exit, or the strategic integration the AMPL rebrand hints at.

What the bear case requires

Three documented issues warrant scrutiny. The LLP held 2.03% before its June 12 disclosed purchase — silent accumulation under the 5% disclosure threshold, meaning buying began well before the visible window. Supriya Kataria’s 8.06% pre-existing holding surfaced as PAC only in the June 30 announcement, absent from every prior SAST filing. The announcement itself identifies Santosh Kataria as “person in control of Acquirer-1” while not disclosing him as a person acting in concert. Separately, Kanoria and Mohit K Chheda are co-directors in Credent Investment Private Limited — a documented information proximity between the warrant subscriber and the exiting director.

Where I land

Watch, not buy. Fundamentals and insider alignment are real, but the regulatory path has too many binary outcomes to underwrite yet.

Would tighten the case: clearance of the letter of offer without revised PAC disclosures; EGM approval of Kanoria’s warrants (minority-only vote, not automatic given the post-Chheda register); strategic clarity on the AMPL rebrand.

Would flip it to avoid: any order requiring PAC restatement; EGM rejection of Kanoria’s warrants; any RBI signal on NBFC licence continuity.

Worth tracking daily.

Sources. All filings referenced are public. Kataria LLP acquisitions and Chheda group exits filed under SEBI SAST Regulation 29(2) between June 4 and July 2, 2026. Public announcement of the open offer filed under SEBI SAST Regulation 3(1) on June 30, 2026. Kanoria warrant subscription board approval dated May 30, 2026. Certificate of Incorporation for name change from ROC Mumbai dated June 20, 2026. Financial data from Screener.in. Directorship records from MCA / Trendlyne.

Disclosure. I do not hold a position in AMPL Capital Limited (BSE: 539598). I am tracking the situation closely. I am not a SEBI-registered research analyst. This is personal research shared for discussion — not investment advice or a recommendation.

NINtec Systems Ltd (BSE: 539843) has tripled. From a 52-week low of ₹281 to a recent ₹782 — up 178% in last 3 months — the stock trades at 94% of its all-time high, capitalising at ₹1,447 Cr and pricing in 51x earnings.

For a sub-₹200 Cr standalone-revenue IT services company, that is not a cheap valuation. The market is paying for compounding, not for value. The question this post tries to answer is what, exactly, is being priced — and whether the recent moves justify the multiple.

The short answer: the company is in the middle of a genuine, coordinated transformation toward AI-first European IT services. The fundamentals supporting it are real. The governance scaffolding around it has gaps that any serious buyer at these prices should weigh.

The four-month sequence

What looks at first glance like several unrelated filings is one continuous, managed transition:

• Jan–Feb 2026 — Two new Independent Directors appointed (28 Jan); two sitting IDs resign together (10 Feb), with one also exiting the Netherlands subsidiary board.

• 8 May 2026 — Simultaneous resignations of the CHRO and Head of SEPG.

• 27 May 2026 — FY26 audited results released, unmodified opinion; new internal auditor appointed.

• 19 June 2026 — Netherlands subsidiary discloses a €1.10 million perpetual AI partnership with an unnamed Finland firm — the same day as the first promoter open-market purchase.

• 19–26 June 2026 — Promoter group acquires 19,500 shares across three tranches at near-52-week-high prices; MD re-appointed for a fresh five-year term on 26 June.

Each filing is routine on its own. In sequence — board cleared, strategy reset, management transitioned, AI deal announced the day the promoter starts buying — they’re not five accidents.

What the bull case requires

For the current valuation to hold, three things need to be true.

The transformation is real, not theatre. The €1.10 million Finland deal is small relative to NINtec’s market cap — about 0.8%. But “perpetual strategic technology partnership” with a European AI-native firm building autonomous chatbots and enterprise AI agents is not a generic project win. Management’s framing of it as “one of several being closed” implies a pipeline. The Netherlands subsidiary contributed roughly 40% of FY26 consolidated revenue (~₹68 Cr). If the pipeline produces two to three additional disclosed contracts of similar or larger size by Q2 FY27, the subsidiary could compound at 30%+ YoY and validate the multiple.

The fundamentals are genuinely best-in-class for the segment. FY26 consolidated revenue ₹170 Cr (+21.7% YoY), EBITDA ₹43.6 Cr (+32.8%), PAT ₹32 Cr (+21.6%). EBITDA margins expanded 210 basis points to 25.6%. ROE 40%, ROCE 53%, near-zero debt. These metrics are rare in Indian IT mid-tier — most peers operate at 18-22% margins and 22-28% ROE.

The insiders are pricing forward visibility into their own buys. Promoter Niraj Gemawat, along with persons acting in concert (wife Rachana Gemawat, father Chhaganraj Gemawat, Gateway Group CEO Indrajeet Mitra, and corporate entity VIN IT Solutions LLP), purchased 19,500 shares across three tranches in a compressed nine-day window starting the same day as the Finland announcement. The aggregate promoter holding moved from 18.30% to 18.40% — small in percentage terms, symbolically significant given the timing and the price level. Indrajeet Mitra’s Gateway Group operates across 30+ countries with documented Nordic and European presence, the most plausible source of the AI pipeline.

What the bear case requires

For the multiple to compress, only one of the following needs to surface.

• The new board is untested. The recently appointed Independent Directors have no prior public board history. Indian smallcap boards routinely include directors from varied backgrounds, so this isn’t disqualifying — but the body that has to oversee a strategy pivot has only been in place since February.

• Promoter holding is structurally thin at 18.40%. The founding group operates the company but does not own it. Minorities are exposed to related-party dynamics with the wider Gateway Group ecosystem — notably TGIF Agribusiness Limited, where both outgoing directors held parallel board seats.

• Current valuation leaves no margin for slippage. At 94% of the 52-week high, a single soft quarter, a contract delay, or any audit-side surprise could trigger a 20-30% drawdown.

Where I land

This is a watch, not a buy at these levels. The fundamental quality is real. The transformation is genuinely underway. But the entry price asks for near-flawless execution and the governance scaffolding has not yet earned that trust.

Three things would tighten the case before adding a position:

1. Q1 FY27 results (mid-August) — first quarter capturing Finland deal revenue. Subsidiary growth of 30%+ YoY would validate the pipeline thesis.

2. A second AI contract disclosure within 60-90 days, ideally with a named counterparty and a disclosed contract value.

3. Promoter group crossing the 19% holding threshold — sustained accumulation at higher prices would shift this from “buying around an announcement” to genuine insider conviction.

Three red flags that would flip this to avoid:

1. A third senior management or director exit before September.

2. Any related-party transaction disclosure with Gateway Group entities in the next Annual Report.

3. An auditor qualification on FY27 results.

A high-quality compounding small-cap, mid-transformation, at a price that demands the transformation succeed. Worth tracking. Not yet worth owning.

Sources. All filings referenced are public. Disclosures via BSE under SEBI LODR Reg 30 — particularly the 28 Jan, 10 Feb, 8 May, 19 Jun, and 26 Jun 2026 announcements. Promoter purchase disclosures filed under SEBI SAST Reg 29(2) on 20, 24, and 26 June 2026. Financial data from NINtec’s Q4 FY26 results filing dated 28 May 2026 and Screener.in.

Disclosure. I do not hold a position in NINtec Systems Ltd. Not SEBI registered - this is research, not a recommendation.

The exchange filings, read in order, tell a completely different story.

Three vehicles, one family, 18 months

Through that same 18 months, three separate buying programs were running in Daikaffil’s open market — and they all trace back to the same controlling group.

Vehicle 1 — Direct board control (2024). Sometime in 2024, Raghuram Kanyan Shetty — founder and Managing Director of Heranba Industries Ltd (the listed agrochemical major) — became Managing Director of Daikaffil. The Shetty family had operational control of the target before the accumulation visibly began.

Vehicle 2 — SAMS Industries Private Limited (Nov 2024 – Apr 2025). SAMS, a private company whose directors are Raghuram Kanyan Shetty and his sons Roshan Raghuram Shetty and Raunak Raghuram Shetty, ran an open-market accumulation through eighteen+ separate tranches over five months. SAMS’s registered email resolves to abdul@heranba.com — the same domain as Heranba Industries.

Vehicle 3 — Roshan R Shetty on the Daikaffil board (Aug 2025). On 12 August 2025, Roshan Raghuram Shetty — Raghuram’s son and a SAMS director — was appointed to Daikaffil’s board as Additional Director (Executive, Non-Independent). The family deepened its board control midway through the drawdown.

Vehicle 4 — Mikusu India Private Limited (June 2026 → ongoing). Mikusu is a wholly-owned subsidiary of Heranba Industries, with Raghuram K. Shetty on its board. From 4 June 2026 onward, Mikusu has been disclosed buying Daikaffil on most trading sessions — small tranches of 1,800 to 13,000 shares, with a fresh disclosure within a day of each trade. Combined promoter group holding has moved past 49.26%.

So this isn’t a “Heranba just spotted Daikaffil last fortnight” story. It’s a continuous, eighteen-month, multi-vehicle accumulation by the same controlling family. The June 2026 buying matters because it marks the moment the listed parent itself — Heranba Industries, not just a family SPV — committed its own balance sheet to the program via its subsidiary.

A respected microcap investor whose shareholding patterns I track has held approximately 1.7% of Daikaffil consistently through this entire drawdown — his presence in the 2024 filings was what got me to dig into the name in the first place.

What the family is buying into

Daikaffil’s standalone numbers are not pretty. Trailing ROE of −27.4%. Trailing ROCE of −27.8%. P/E reported as 11.2x looks reasonable only because earnings are distorted to the point of being meaningless. As a standalone investment, Daikaffil is a financially distressed micro-cap with a market cap of ₹31 Cr.

But Daikaffil’s plant sits in MIDC Tarapur (Boisar, Maharashtra) — one of India’s most strategically located specialty-chemicals industrial belts. Heranba, as a listed agrochemical company, has the operational machinery to turn around the manufacturing — and the corporate-action vehicles to consolidate ownership cheaply while the price is depressed. Distressed targets in strategic geographies are exactly the kind of asset a strategic acquirer wants when the alternative is paying greenfield prices for new capacity.

The 88% drawdown wasn’t the thesis breaking. It was retail capitulation while a known strategic acquirer accumulated on the other side of the tape.

Why this looks like an endgame setup, not a news pop

The June 2026 Mikusu buying is interesting on its own — daily disclosures of accumulation by a listed company’s subsidiary into a sub-50% promoter holding are unusual — but it’s more interesting in the context of what’s already been built. The gap from 49.26% to 50% is roughly 44,000 shares on a 6-million-share base, which at the current pace of buying is a matter of days, not weeks. Crossing 50% is symbolically meaningful but, on its own, not the structural endgame.

The structural endgame is one of two things: a formal delisting offer, or a scheme of arrangement merging Daikaffil into the Heranba group, which requires NCLT approval. Either route eventually requires a formal corporate-action announcement from Heranba — not just continued creeping.

The free float in absolute rupees is roughly ₹14 Cr — small enough that Heranba’s balance sheet absorbs the entire remaining public float at current prices for a low double-digit crore commitment. Whatever the family is preparing — delisting, merger, or absorption of the Tarapur asset into Heranba’s manufacturing footprint — the corporate-action filing is the catalyst that retroactively justifies the 18 months of buying.

The bear case that’s actually real

I’m a holder, not a cheerleader:

• The fundamentals are still bad. Negative ROE/ROCE means there’s no organic value to wait on. The thesis depends entirely on a corporate-action catalyst — without one, this is a value trap with an extractive promoter.

• Heranba could stop short. SEBI’s SAST regulations let a creeping acquirer go to ~54.26% (5% per financial year above the existing base) without triggering an open offer. The family could consolidate effective control and never offer minorities an exit, leaving public holders trapped in an illiquid nano-cap where related-party transactions extract value over time.

A creeping acquisition by a credible strategic acquirer shifts probability; it does not eliminate the trap risk.

What I’m watching

• Combined promoter holding crossing 50% — likely within days at current pace.

• Heranba’s own filings — any board outcome from the listed parent referencing Daikaffil (an acquisition disclosure, related-party approval, scheme of arrangement) is the formal catalyst.

• A formal corporate-action announcement from Heranba. The two realistic endgames — a delisting offer or a scheme of arrangement merging Daikaffil into the Heranba group — both need a formal disclosure, not just continued creeping. That filing is the catalyst, whenever it comes.

• Annual Report FY2026 (due September 2026) — will reveal the full extent of related-party transactions and any explicit strategic alignment with the Heranba group.

Disclosure: I have held Daikaffil Chemicals (BSE: 530825) since 2024 and averaged down through the drawdown. I am not SEBI-registered. Nothing here is investment advice.

Sources: BSE 530825 filings page · SAST 29(2) disclosures by SAMS Industries Private Limited (Nov 2024 – Apr 2025) · Change in Directorate intimation — appointment of Roshan Raghuram Shetty (Aug 12, 2025) · SAST 29(2) disclosures by Mikusu India Private Limited (Jun 4 – Jun 17, 2026) · Daikaffil annual filings for promoter holding · MCA records for SAMS Industries Pvt Ltd (CIN U24110MH1994PTC082301) directors · Heranba Industries Ltd corporate disclosures listing Mikusu India as a wholly-owned subsidiary · Shareholding tracker for the referenced microcap investor’s Daikaffil position.

Then, between 22 May and 5 June 2026, three filings landed on the BSE inside a 14-day window. Each said something. Read together, they said something else.

1. The Court signed off on a structural cleanup nine months in the making

On 22 May 2026, the NCLT Chandigarh Bench-II approved the amalgamation of two subsidiaries directly into NIIT Limited: NIIT Institute of Finance Banking & Insurance Training Ltd (IFBI) — the BFSI training arm originally set up in partnership with ICICI Bank — and RPS Consulting Private Limited, a Bengaluru-based IT training firm in which NIIT had acquired 70% in October 2021. The board had approved the scheme back in October 2025; the 22 May order is the legal trigger, with appointed date 1 April 2026.

Worth being honest about what the merger does not change. Both subsidiaries were already inside NIIT’s consolidated P&L — RPS’s 30% minority shows up as a ₹6.48 Mn “Non-Controlling Interests” line in the audited FY26 consolidated results filed on 14 May. There is no overnight step-up in consolidated revenue when these subsidiaries merge in. What the order does deliver: the 30% RPS minority gets settled via share exchange and disappears, legal structure simplifies, tax inefficiencies tighten, and the holding-company discount the market historically applies to fragmented listcos narrows. Structural cleanup — not headline-number uplift.

2. Both co-founders bought, in mirror, the same week

Ten days after the NCLT order, between 1 June and 4 June 2026, two SAST 29(2) filings landed:

• Pawar Family Trust — Rajendra Singh Pawar (co-founder & Executive Chairman) — 19,53,500 shares, 17.74% → 19.17%

• Thadani Family Trust — Vijay Kumar Thadani (co-founder & Managing Director) — 19,53,500 shares, 18.14% → 19.57%

Combined promoter PAC holding moved from 36.94% to 39.80% in four trading days. Both founders bought the exact same number of shares (19,53,500), through the same four-day window, via plain open-market purchase. The stock moved from ₹81.54 on 1 June to ₹93.44 on 4 June — a +14% mark-up inside their own buying window.

Pawar and Thadani co-founded NIIT in 1981 and have run it together for 45 years. Two people with that much shared operational context placing the identical trade in the identical week is not coincidence. It’s a coordinated, conviction-driven add by the principals with the most ground-truth on the business — placed in the lower half of the 12-month range (still ~30–40% below the ₹133 high), ten days after the Court signed off on the structural cleanup they had been arranging for nine months.

3. The AI bet has been compounding quietly for fourteen months

On 17 April 2025, NIIT acquired a 70% stake in iamneo — a Coimbatore-based, AI-powered deep-skilling SaaS platform — for ₹61.3 crore, with the remaining 30% to be acquired on milestones.

That deal isn’t news. What is new is the first audited full year that includes it. NIIT’s FY26 investor presentation (14 May 2026) discloses:

• FY26 overall revenue ₹390.2 Cr (+9% YoY); iamneo contributed ₹41.3 Cr — ~10.6% of total revenue at 14 months in.

• In Q4 FY26, organic revenue grew only +1% YoY — the entire +16% headline came from iamneo.

• FY26 EBITDA was a small loss (₹−4 Cr vs ₹+11.5 Cr in FY25).

The legacy training business has stalled; the new acquisition is doing essentially all of the growth. That is either the bear case (legacy melting, dependent on the new bet) or the bull case (AI pivot real, growing, already at ~10% of revenue with a path to materially more). The founders’ open-market buying after the FY26 audited numbers is a vote on which read they hold. Add the gNIIT dual-qualification undergraduate program (launched 2025), and the direction is consistent: NIIT is trying to stop being valued as a legacy training brand and start being valued as an enterprise-and-higher-ed skilling platform with an AI-native delivery layer.

Why this looks more like a setup than a news pop

A 62% drawdown over nine months doesn’t get fully reversed by one quarter of structural disclosure. Even at ₹105.72, NIIT is still ~21% below the 12-month high and 33% below where the drawdown started — the room a re-rating can travel is mostly still there.

And these three filings aren’t one news event; they resolve into three separate future data points the market gets to react to: Q1 FY27 results (cleaned-up structure, first read on whether organic growth has stopped contracting), further SAST 29(2) disclosures (does founder accumulation continue toward the SAST creep-acquisition ceiling), and the iamneo line item maturing in investor communication. That’s a multi-quarter setup, not a one-day repricing.

The bear case that’s actually real

Three things genuinely keep this short of a “back-up-the-truck” rating:

• FY26 EBITDA flipped to a small loss. Investment mode either produces operating leverage in 18–24 months or it doesn’t.

• Q4 organic revenue grew only +1%. iamneo is carrying the whole top line — concentration risk if that line stumbles before the legacy business stabilises.

• Tax overhang. The NCLT order explicitly preserves the Income Tax Department’s right to investigate the scheme for tax avoidance. The principle — authorities watching the structure — matters more than the absolute amounts.

A founder buy and a Court order don’t override these. They shift probability and timing, not the underlying business risk.

What I’m watching

• Q1 FY27 results (Jul–Aug 2026) — first read on whether organic growth has stopped contracting, and the EBITDA trajectory as iamneo scales.

• Further SAST disclosures from the trusts — every additional founder buy is incremental confirmation.

• iamneo and gNIIT line items breaking out separately in investor communication — when the company starts reporting the AI-skilling line as a distinct segment, the market gets a separate dataset to value the pivot on.

Disclosure: I have held NIIT Limited (BSE: 500304) since 2025 and added more in June 2026 after reading the filings discussed above. I am not SEBI-registered. Nothing here is investment advice.

The transformation

The timeline reads like a step-by-step playbook:

• Oct 16, 2025 — Sumuka files the EGM Notice for a Scheme of Merger by Absorption with Gujjubhai Foods Private Limited

• Nov 18, 2025 — Shareholders approve at the court-convened meeting

• Feb 4, 2026 — NCLT Mumbai sanctions the scheme

• Mar 20, 2026 — Sumuka allots 1,38,13,666 new shares at a swap ratio of 7 Sumuka shares for every 4 Gujjubhai Foods shares

• May 22, 2026 — Listing entity renamed to Gujjubhai Industries; new BSE scrip name ‘GUJJUBHAI’ effective May 26

The business being absorbed is real

Per audited financials in the Oct 16, 2025 EGM Notice:

FY23FY24FY25Revenue₹13.14 Cr₹22.06 Cr₹49.77 CrPAT₹1.68 Cr₹1.32 Cr₹1.99 Cr

Roughly 3.8x revenue growth over two years, with thin ~4% PAT margins, and net worth disclosed as under ₹10 Cr at the time of merger. Not paper. The Registered Valuer’s report and Merchant Banker’s Fairness Opinion supporting the 7:4 swap ratio are part of the EGM filing — anyone who wants to question the ratio has the underlying documents.

What the market has done about it

Through the entire scheme execution period — NCLT sanction, allotment, name change, Arkaa announcement — the stock has fallen ~54% from its 52-week high of ₹271 to around ₹125 today.

On a per-share basis, this is the math of dilution working through the market: the merger added 1.38 Cr new shares (a 2.94x expansion of the share count), and the market is also pre-pricing further dilution from the pending Arkaa share swap. The listing entity is bigger by enterprise value than a year ago — it has absorbed Gujjubhai Foods’ ₹50 Cr revenue business — but each pre-merger share now represents only ~34% of the listed equity it once did.

Existing shareholders own the same number of shares as before, but those shares now represent a smaller slice of a bigger company.

The next domino: Arkaa Cluster

Within days of the scheme becoming effective, Gujjubhai announced a binding term sheet dated March 19, 2026 to acquire 100% of Arkaa Cluster Private Limited for ₹35 Cr — again via share swap, not cash.

Per the term sheet:

• Arkaa is engaged in food trading, agro commodities, warehousing

• Holds an investment in Urban Millets Pvt Ltd, which operates the ‘True Millet’ brand

• Revenue trajectory: ₹10.88 Cr (FY23) → ₹150.61 Cr (FY25) — roughly 13x in two years

Arkaa’s PAT, net worth, and the independent valuation report supporting the ₹35 Cr price tag are not yet public. Under Section 247 of the Companies Act 2013, any preferential allotment for consideration other than cash requires a Registered Valuer’s report, which by law must accompany the formal preferential allotment EGM notice when filed. Until that filing drops, the ₹35 Cr valuation can’t be assessed independently.

If Arkaa closes as outlined, total dilution from the original Sumuka base reaches ~3.2x. Every capital event in this sequence has been a share swap, not a cash event.

Behavioral signal from the promoter side

Three small SAST 29(2) disclosures hit the exchange between June 8 and 10 — Bhatt (+0.017%), Patel (+0.0001%), and Kingsman Wealth Management (+0.137%, from 12.865% to 13.0027%). Total combined commitment is under ₹50 lakhs. These are nominal, disclosure-triggered transactions, not material capital deployment. The signal is behavioral — the promoter network is on the buy side, not the sell side — but the magnitude doesn’t warrant treating it as a conviction call.

Two named allottees in the merger scheme are worth noting (per Trendlyne portfolio data, not BSE filings):

• Ghanshyam J Patel — Mumbai-based investor, ~₹140 Cr tracked portfolio

• Shilpa M R — director-level, ~₹57 Cr across 19 stocks

External capital that ran its own diligence chose to participate.

What’s coming next

• Arkaa preferential allotment EGM notice — brings the Registered Valuer’s report, audited financials of Arkaa, and exact dilution quantum

• Q1 FY27 results — first read on what the merged business actually delivers

• Continued SAST creep buying — if accumulation continues meaningfully (not nominal disclosure-triggered amounts), it confirms build-out conviction

• Any QIP/rights issue — would signal management willingness to bring cash rather than more share swaps

What’s cautious

• Arkaa’s ₹35 Cr valuation isn’t independently testable until the EGM notice drops

• Dilution from 71 lakh shares to a potential 2.4+ Cr shares is real and serial — every capital event so far has diluted public shareholders without adding cash to the company

• Filing infrastructure is informal (Gmail-based corporate communication, drafting errors in SAST filings) — typical of Indian micro-caps at this scale, worth noting as scale context rather than a governance red flag

I do not hold a position in Gujjubhai Industries Ltd. I’ve started tracking it. Nothing in this post is investment advice — I am not SEBI-registered. Do your own work.

Sources: BSE 532070 filings page · EGM Notice (Oct 16, 2025) · Court Meeting Outcome (Nov 18, 2025) · NCLT Mumbai Order (Feb 4, 2026) · Arkaa Binding Term Sheet (Mar 19, 2026) · Scheme Allotment (Mar 20, 2026) · Name Change (May 22, 2026) · SAST 29(2) disclosures (Jun 8-10, 2026).

Most special situations have one storyline. RNIT AI Solutions has three running in parallel, and they’ve started to braid together over the last six months.

The company: RNIT AI Solutions Ltd (BSE: 517286), market cap ₹577 Cr, formerly known as Autopal Industries. A nano-cap by float — only ~₹160 Cr is genuinely tradeable.

The setup: What happens when a debt-laden auto components company emerges from NCLT, renames itself, raises capital from credible tech investors, and signs a state government contract — all in under two years.

Let me walk through what I see.

Thread 1 — The IBC reset

In September 2024, the NCLT Jaipur approved a resolution plan for the company then called Autopal Industries. That single legal event extinguished legacy industrial liabilities and gave the surviving entity a clean balance sheet.

This is the unglamorous foundation of every IBC turnaround. Without the resolution, none of what follows is possible. The company that exists today is structurally different from the one that went into insolvency — same listing, same scrip code, different liability profile and ambition.

Reset done. Clean slate. Starting at zero.

Thread 2 — Smart money fills the slate

Then came the capital.

₹47.16 Cr raised across two preferential tranches:

• Tranche 1: ₹20.83 Cr on November 5, 2025, fully deployed by March 31, 2026

• Tranche 2: ₹26.33 Cr on March 28, 2026, yet to be deployed

Both at ₹50/share — well below current trading levels, but not by a panic-inducing margin. The market has re-rated since the tranches closed. That gap itself is informative; investors put money in at prices that the market has since validated.

But the more important signal is who showed up:

• The Katkar family — Sanjay Katkar (co-founder & CTO of Quick Heal Technologies), Chhaya S. Katkar, and Anupama K. Katkar — collectively holding ~38.97 lakh shares (~4.60% post-allotment). Their combined tracked portfolio is north of ₹920 Cr. They’re not promoters here. They’re investors choosing to back an AI-pivot company.

• SageOne Investments’ Flagship Growth OE Fund — 10 lakh shares (~1.18%), ₹191.5 Cr AUM, known for quality-growth small/mid-caps. Their participation says an institutional process found this credible.

• Nishid Babulal Shah — a Mumbai-based investor with a ~₹95 Cr tracked portfolio in micro/small-caps. Often co-invests alongside family-network capital.

• G Santosh Kumar — ~₹72.6 Cr across 12 micro-cap stocks.

Each one alone is a data point. Together they look like an informed cluster — the kind of overlap that often shows up after one of them does the diligence and the rest follow on conviction.

Thread 3 — Revenue validation from a state government

Three days after the second preferential allotment closed, on March 16, 2026, RNIT executed a Service Level Agreement with the Commissionerate of Higher Education, Government of Andhra Pradesh.

The contract: deploy an AI-based mobile-driven Facial Recognition Attendance Management System across ~3,900 higher education institutions covering ~1.3 million users.

This is the part that turns the story from “preferential allotment in an IBC-cleaned shell” into “the company has a product that a state government is willing to pay for at scale”.

Three things worth noting about this SLA:

1. It’s a Service Level Agreement, not a letter of intent or MoU. That’s a real commercial contract with deliverables.

2. The timing is tight. Capital raised in late March → government contract signed two weeks later. The first ₹20.83 Cr tranche almost certainly funded the capability build that the AP government then bought.

3. The deployment is staggered. The ₹26.33 Cr second tranche is sitting unutilized, earmarked for the scale-up across 3,900 institutions. That’s the next visible milestone.

Why the convergence matters

Each thread alone is interesting. Together they form a coherent operating sequence:

IBC resolution → fresh capital from credible investors → product validation by a state government → unutilized capital ready to fund scale-out.

That’s a structured re-birth pattern, not a coincidence. When three threads of this kind converge in the same six-month window, the probability that they’re individually random drops to near zero. Someone is running a plan.

At ₹577 Cr market cap and ₹160 Cr free float, each visible event is genuinely needle-moving for the stock. The stock now trades around ₹63-64 — roughly 25-30% above the ₹50 anchor price for both tranches. The market has partially re-rated the AI-tech SaaS thesis, but the operational delivery is still ahead.

What’s concerning

A few things I’m watching closely:

• Execution risk is the dominant variable. This was Autopal Industries — an auto components business — eighteen months ago. Deploying a biometric AI system across 1.3 million users across 3,900 institutions is a very different operational challenge. The team hasn’t publicly demonstrated this delivery at scale yet.

• The AP contract economics are opaque. No disclosed floor revenue, no minimum transaction volume guarantee. The pricing is per-authentication. If adoption is slow, or the state government’s enforcement of attendance mandates is weak, the revenue could underwhelm.

• Two-year contract, no stated renewal terms. Revenue visibility extends to FY27-28 at best.

• Allottee opacity. Among the preferential allottees are Visionary Vibes Consultancy (incorporated 2025, real estate/consultancy, Pune) and Mehak Finpro India Pvt Ltd — entities without disclosed UBO information. That’s a related-party / pass-through risk worth flagging.

• The ₹26.33 Cr second tranche remains entirely unutilized.

• Free float of ₹160 Cr makes the stock susceptible to pump-and-dump dynamics given the narrative-driven nature of the AI-pivot story.

What I’m watching for

Immediate (Apr-Jun 2026):

• Q4 FY26 earnings — first results post-rebrand. Whether any AI-segment revenue actually shows up.

• Any BSE filing or press release about the AP contract going live — i.e., first institutional deployments. That’s the operational milestone the second tranche was raised for.

Near-term (Jun-Sep 2026):

• Q1 FY27 results — first quarter where AI revenue could meaningfully appear.

• Tender announcements from other state governments (Bihar, Telangana, Rajasthan education departments) — would validate the model is replicable.

• Board composition changes — if the Katkar family or SageOne nominates a director, that’s a meaningful escalation of commitment.

Medium-term (Sep-Dec 2026):

• AGM disclosures — promoter/resolution applicant identity clarity, any strategic partnership announcements.

• Half-yearly shareholding pattern — to see if the smart-money allottees are holding or trimming.

Risk watch:

• Absence of new contracts by Q2 FY27

• First institutional deployment under the AP contract slips past Q2 FY27 without explanation

• Insider trading filings showing smart-money allottees exiting

Why this is on my watchlist (and why I have a position)

The investment case has genuinely compelling elements: Katkar family (Quick Heal founders) and SageOne as allottees is rare smart-money validation for a nano-cap IBC turnaround; the AP government SLA is a real, signed contract (not an MoU) covering 1.3 million users; IBC resolution provides a clean-slate balance sheet; and capital deployment discipline (zero deviation in tranche 1) is encouraging.

The conviction is capped at medium because the company is pre-revenue on its AI pivot at this scale, contract financial terms are undisclosed, and UBO opacity in several allottee entities raises governance questions.

I’ve taken a small position sized for the optionality: enough that a successful scale-up is meaningful, small enough that a Q2 deviation filing or a missed deployment milestone doesn’t hurt.

Position disclosure

I hold a small position in RNIT AI Solutions Ltd (BSE: 517286). Position size is small relative to my book — I’ve sized it for the optionality on the AP contract scale-out, not for a high-conviction concentration. I may add or trim based on Q1 FY27 results — first window into AI-segment revenue recognition.

Sources

• BSE RNIT AI Solutions filings page (517286)

• NCLT Jaipur Resolution Plan order (September 23, 2024)

• Preferential allotment Tranche 1 outcome (November 5, 2025)

• Preferential allotment Tranche 2 outcome (March 28, 2026)

• Service Level Agreement disclosure with Commissionerate of Higher Education, Government of AP (March 16, 2026)

• Regulation 32 filing — utilization of preferential issue proceeds (April 29, 2026)

Nothing in this post is investment advice. I’m not SEBI-registered. I hold a small position as disclosed above. Do your own work.

I was flipping through last week’s filings when one EGM notice stopped me.

A small Hyderabad-based machine tools company — Lokesh Machines Ltd (BSE: 532740) — was running a multi-tranche preferential allotment. Routine on the surface. But the allottee list had a name I didn’t recognise: Zandra Herbs & Plantations LLP, an Ahmedabad-registered LLP.

So I pulled the UBO disclosure.

The Ultimate Beneficial Owners turned out to be Sharvil Ramanbhai Patel and Pankaj Ramanbhai Patel — the Chairman and Managing Director, respectively, of Zydus Lifesciences (formerly Cadila Healthcare). Pankaj Patel alone has a disclosed net worth north of ₹80,000 Cr.

That is not a name you expect to see at the bottom of a small-cap machine tools company’s allottee table.

Why the entry structure is interesting

Two things stood out.

First, the vehicle. The Patels didn’t invest through Zydus, or through any of their visible pharma holding companies. They used a fresh LLP — Zandra Herbs & Plantations — registered in Ahmedabad. That’s a deliberately low-visibility structure. It says personal/family bet, not strategic acquisition.

Second, the disclosure quality. The original EGM notice from March 12, 2026 did not name the UBOs. The UBO disclosure was only added via an April 27, 2026 amendment — likely after regulatory scrutiny. The deal is now being structured to comply fully before the shareholder vote.

That’s a red flag about the initial disclosure quality, but also a green flag about who’s behind it — they cared enough to clean up the filing rather than withdraw.

The parallel thread: promoter accumulation

While reading the same set of filings, a second thread emerged. The promoters of Lokesh Machines are themselves deepening their position — in two distinct moves.

Move 1 (already done): On June 26, 2025, three promoters — Mullapudi Lokeswara Rao (founder/MD), Mullapudi Srinivas (WTD), and Bollineni Kishore Babu (WTD) — converted warrants into 4,03,040 equity shares at ₹243.25/share, putting roughly ₹9.80 Cr of their own money into the company. That’s a clean conviction signal.

Move 2 (in motion): The April 27, 2026 filing brings in five new promoter-group members — including additional Bollineni and Mullapudi family members — who are now subscribing to equity shares directly, while non-family promoters and KMPs are restricted to warrants.

That’s a dual-structure that does two things:

• It phases promoter commitment (warrants convert later, with skin-in-the-game milestones)

• It expands the promoter group via family lines, which has both governance implications and a ‘doubling down’ signal

What I find interesting about the combo

It’s rare to see two capital infusion threads converge in the same set of filings. You usually see one — either smart money entry, or promoter accumulation. Here you have both, staggered, and structurally linked.

The Patel family’s involvement is the more eye-catching of the two — but it’s also the more opaque. There’s no public statement explaining why a pharma billionaire family is taking a personal stake in a CNC and Special Purpose Machine (SPM) manufacturer. A few possibilities:

• A personal/family office allocation, treating Lokesh as one of several industrial small-cap bets

• An early positioning for a future strategic or commercial relationship — pharma manufacturing uses precision machinery, so there’s a plausible (but unverified) crossover angle worth exploring

• A bet on the broader Indian capex theme via a small undervalued operating company

The promoter accumulation alongside it is the simpler signal — insiders putting in real money at a specific anchor price (₹243.25), with a phased structure that staggers commitment.

What I’m cautious about

A few things worth naming clearly:

• The strategic thesis is not articulated anywhere. No Zydus statement, no Lokesh management commentary on the Patel investment. We’re inferring intent from structure.

• The original disclosure was incomplete. The UBO amendment was reactive, not proactive. That tells you something about deal hygiene.

• The LLP vehicle adds opacity. Family offices using LLPs is normal — but it does mean you’ll have less ongoing visibility into the Patel exposure (no quarterly shareholding patterns, no insider trading disclosures from this vehicle).

• Multiple new promoter-group additions create governance complexity. Five new names entering the promoter group in one tranche is a lot. Worth tracking how the post-allotment shareholding pattern shapes up.

What I’m watching for

• EGM date and vote outcome — whether the resolutions pass cleanly

• Post-allotment shareholding pattern filing — to see the actual promoter concentration after the new family additions

• Any Zydus Lifesciences capex announcement in pharma machinery — would validate the strategic angle

• Lokesh management commentary in upcoming quarterly results — first chance for them to address the Patel investment publicly

• Any further allottee additions in revised filings

Position disclosure

I don’t hold a position in Lokesh Machines. This is a setup I’m watching, not a stock I’m in.

Disclosure updated Aug 2026: I have since taken a small position in Lokesh Machines.

Sources

• BSE Lokesh Machines filings page (532740)

• EGM Notice dated March 12, 2026 — original preferential allotment notice (Zandra Herbs & Plantations LLP among allottees; UBO not disclosed in this version)

• EGM Notice Amendment dated April 27, 2026 — adds UBO disclosure identifying Sharvil & Pankaj Patel as the beneficial owners of Zandra Herbs LLP

• Clarification dated April 28, 2026 — adds new promoter-group members subscribing to equity shares; lays out the warrant-vs-equity dual structure

• Warrant Conversion disclosure dated June 26, 2025 — three promoters converted warrants into 4,03,040 equity shares at ₹243.25/share (~₹9.80 Cr)

Nothing in this post is investment advice. I’m not SEBI-registered. Verify everything yourself.

They don’t appear on TV. They don’t issue tip-sheets. They read every preferential allotment notice, every scheme of arrangement, every change-in-control disclosure — and they piece together stories that the rest of the market only catches up to months or quarters later.

I’ve learnt most of what I know from following them.

This blog is my attempt to do the same kind of work — with one difference: I use AI to do the grunt work of reading every filing across BSE, so I can spend my time on the parts that actually require judgement.

What’s changed recently

For most of the last decade, this kind of analysis had a hard ceiling: you could only read so many filings in a day. Even the best analysts had to pick a watchlist of 30–50 companies and trust that the next multibagger was hiding inside that list.

That’s no longer the constraint.

I run a screening pipeline that pulls every event-driven filing that matters from BSE; the model reads each filing’s PDF, extracts structured facts (acquirers, allottees, valuation reports, target financials, scheme details), researches every entity involved, and surfaces the 5% of filings that are actually interesting.

The other 95% - routine ESOP allotments, technical pledge releases, CFO changes at companies no one’s heard of - gets filtered out automatically.

What this gives me is the ability to scan the whole market every day, not a watchlist of 50 names. That’s where the edge is now: not in being smarter than the next analyst, but in being able to see structural changes happening in micro-caps that no analyst (or AI) was previously paying attention to.

What you’ll find here

• Setup notes when something interesting shows up in filings — usually small/micro/nano-caps where smart money is just starting to position

• Deep dives on companies going through structural change — IBC turnarounds, business pivots, control transitions, demergers

• Pattern notes on who’s buying what — when a known investor enters a name quietly, that’s worth flagging

• Mistakes — when I’m wrong, I’ll say so. The point of writing publicly is to learn faster.

A note on how this gets made: most posts here are enabled by a screening tool I’ve built for myself — it reads filings, surfaces patterns, and flags entities worth investigating. AI does the grunt work; the judgement and the writing are mine.

The tool surfaces a few hundred potentially interesting situations every month. I'll write about maybe one in fifty — the ones where the story is worth your time. That filter is where my edge sits. I'll be wrong on many of these — special situations have low hit rates by design. The bet isn't on being right often, it's on the few that go up multiples while the rest fizzle quietly.

What I won’t do:

• No tips. Nothing here is a recommendation. I'm not SEBI-registered. I may or may not hold a position in any company I discuss — when I do, I'll say so. Do your own work.

• No hype. No “10x in 30 days.” If the thesis takes 3 years, I’ll say 3 years.

• No paywalls (for now). Maybe later, if there’s enough of you reading.

Why I’m writing this publicly

Two reasons.

One — writing forces me to think more clearly. If I can’t explain why a filing matters in a couple of paragraphs, it probably doesn’t. The blog is a discipline.

Two — there’s a community of investors in India doing this kind of work, and most of them learn from each other in private. I’d like to add to that conversation, not replace it.

If you enjoy reading primary sources, you’ll like it here.

Subscribe if:

• You invest in Indian small / micro / nano-caps and want a slower, more rigorous take

• You’re curious how AI is changing the way primary research gets done

• You’re patient enough to wait for a thesis to play out

- Vipul